Effects of valproate derivatives I. Antiepileptic efficacy of amides, structural analogs and esters

Neuropharmacology

Volumn 39, Issue 2, 2000, Pages 254-266

  Redecker, C ^a   Altrup, U ^a   Hoppe, D ^a   Dusing R ^b   Speckmann, E J ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ALK SCHERAX Arzneimittel GmbH   (Germany)

Author keywords

Anticonvulsants; Epilepsy; Experimental epilepsy models; Helix pomatia; Pentylenetetrazole; Valproate derivatives

Indexed keywords

1 O (2 PROPYLPENTANOYL)MANNITOL; UNCLASSIFIED DRUG; VALPROIC ACID; VALPROIC ACID DERIVATIVE; VALPROMIDE;

ANTICONVULSANT ACTIVITY; ARTICLE; DRUG CONFORMATION; DRUG POTENCY; DRUG SYNTHESIS; EPILEPSY; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMIDES; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; ESTERS; HELIX (SNAILS); STRUCTURE-ACTIVITY RELATIONSHIP; VALPROIC ACID;

EID: 0033989853     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00100-8     Document Type: Article

References (26)

1. Altrup U., Gerlach G., Reith H., Said M.N., Speckmann E.-J. Effects of valproate in a model nervous system (buccal ganglia of Helix pomatia): I - Antiepileptic actions. Epilepsia. 33:1992;741-750.
2. Altrup U., Peters M. Procedure of intracellular staining of neurons in the snail Helix pomatia. Journal of Neuroscientific Methods. 5:1982;161-165.
3. Altrup U., Speckmann E.-J. Epileptic field potentials in the buccal ganglia of Helix pomatia (abstract). Pflügers Archives. 420:1992;63.
4. Altrup U., Speckmann E.-J. Identified neuronal individuals in the buccal ganglia of Helix pomatia. Neuroscience and Behavioral Physiology. 24:1994;23-32.
5. Armand V., Louvel J., Pumain R., Ronco G., Villa P. Effects of various valproic acid derivatives on low-calcium spontaneous epileptiform activity in hippocampal slices. Epilepsy Research. 22:1995;185-192.
6. Badir K., Haj-Yenia A., Vree T.B., van der Kleijn E., Bialer M. Pharmacokinetics and anticonvulsant activity of three monoesteric prodrugs of valroic acid. Pharmaceutical Research. 8:1991;750-753.
7. Baillie T.A., Sheffels P.R. Valproic acid. Chemistry and Biotransformation. Levy R.H., Mattson R.H., Meldrum B.S. Antiepileptic Drugs. 1995;589-604 Raven Press, New York.
8. Benoit-Guyod J.-L., Boucherele A., Carraz G. Preparation de Nouveaux amides de lacide Di-N-propyl-acétique. Bulletin de la Société chimique de France. 1965;1660-1661.
9. Cappochi, G., Fausti, R., Picchiarelli, A., Zampolini, M., Rossi, A., 1989. Tonic status epilepticus induced by valproic acid. In: Abstract volume, 18th International Congress of ILAE, New Delhi.
10. Caspers H., Speckmann E.-J., Lehmenkühler A. DC potentials of the cerebral cortex. Seizure potentials and changes in gas pressure. Reviews of Physiology, Biochemistry and Pharmacology. 106:1987;127-178.
11. Chalazonitis N., Takeuchi H. Amples oscillations du potentiel de membrane induites par le métrazol (neurones autoactifs d'Helix pomatia). Comptes rendus de la Société Biologique. 162:1968;1552-1556.
12. Chapman A., Keane P.E., Meldrum B.S., Simiand J., Verniers J.C. Mechanisms of anticonvulsant action of valproate. Progress in Neurobiology. 19:1982;315-359.
13. Cutler M.G., Horton R.W. Paradoxical enhancement of seizures in the gerbil after chronic treatment with sodium valproate. Neuropharmacology. 27:1988;617-621.
14. Einhorn A., Willstaetter R. Über die p-Methylendihydrobenzoesäure. Justus Liebigs Annalender Chemie. 280:1894;96-159.
15. Fischer E., Dilthey A. Einwirkung von Ammoniak auf die Alkylmalonester. Chemische Berichte. 35:1902;844-856.
16. Keane P.E., Simiand J., Morre M. Comparison of the pharmacological and biochemical profiles of valproic acid (VPA) and its cerebral metabolite (2-en-VPA) after oral administration in mice. Methods and Findings in Experimental and Clinical Pharmacology. 7:1985;83-86.
17. Kupferberg H.J. Antiepileptic drugs. Sodium valproate. Glaser G.H., Penry J.K., Woodbury D.M. Antiepileptic Drugs: Mechanisms of Action. 1980;643-654 Raven Press, New York.
18. Löscher W., Nau H. Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment. Journal of Pharmacology and Experimental Therapeutics. 226:1983;845-854.
19. Lücke A., Lehmenkühler A., Altrup U., Nicholson C., Reith H., Schmitz-Moormann C., Speckmann E.-J. Diffusion analysis of valproate and trans-2-en-valproate in agar and in the cerbral cortex of the rat. Brain Research. 631:1993;187-190.
20. Madeja M., Altrup U., Speckmann E.-J. Synchronization of epileptic discharges: temporal coupling of paroxysmal depolarizations in the buccal ganglia of Helix pomatia. Comparative Biochemistry and Physiology. 94C:1989;585-590.
21. Redecker C., Siep E., Altrup U., Düsing R., Kreier A., Hoppe D., Speckmann E.-J. Epileptogenic and antiepileptic effects if derivates of valproate in a model nervous system (buccal ganglia Helix pomatia). Pflügers Archives. 431:1996;R71.
22. Ruzicka L., Brugger W. Zur Kenntnis des Kohlenstoffringes. V - Über die Ringerweiterung vom acht- zum neungliedrigen Kohlenstoffring. Helvetica Chimica Acta. 9:1926;408.
23. 2-valproate and valproate in rats. Epilepsia. 32:1991;232-241.
24. Speckmann E.-J., Caspers H. Paroxysmal depolarization and changes in action potentials induced by pentylenetetrazol in isolated neurons of Helix pomatia. Epilepsia. 14:1973;397-408.
25. Speckmann E.-J., Elger C.E., Altrup U. Neurophysiologic basis of the EEG. Wyllie E. The Treatment of Epilepsy. Principles and Practice. 1997;204-217 Williams and Wilkins, Baltimore.
26. Walden J., Altrup U., Reith H., Speckmann E.-J. Effects of valproate on early and late potassium currents of single neurons. European Neuropsychopharmacology. 3:1993;137-141.